The Gender-Age-Physiology system as a prognostic model in patients with idiopathic pulmonary fibrosis treated with nintedanib: a longitudinal cohort study.
Mitsuhiro AbeKenji TsushimaKeiichiro YoshiokaMasashi SakayoriKenichi SuzukiYasutaka HirasawaTakeshi KawasakiJun IkariJiro TeradaKoichiro TatsumiPublished in: Advances in respiratory medicine (2021)
The GAP system is useful as a prognostic tool in patients with IPF who have been treated with nintedanib.